No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Five Reasons Why UBS Is Overweight the UK
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week
Have Verona Pharma Insiders Been Selling Stock?
Jefferies Maintains Verona Pharma(VRNA.US) With Buy Rating, Raises Target Price to $50
Verona Pharma Announces December 2024 Investor Conference Participation
Verona Pharma Plc's (NASDAQ:VRNA) Path To Profitability